Charles River Laboratories International (CRL) Amortization of Deferred Charges (2010 - 2016)

Charles River Laboratories International (CRL) has reported Amortization of Deferred Charges for 7 consecutive years, with $506000.0 the latest figure, recorded in Q4 2016.

• In Q4 2016, Amortization of Deferred Charges rose 23.41% year-over-year to $506000.0; the TTM figure through Dec 2016 stood at $2.8 million (up 18.95% YoY), while the FY2016 annual figure was $2.8 million, up 18.95% from the prior year.
• Amortization of Deferred Charges came in at $506000.0 for Q4 2016 at Charles River Laboratories International, up from $34000.0 in the prior quarter.
• The five-year high for Amortization of Deferred Charges was $4.6 million in Q1 2013, with the low at $34000.0 in Q3 2016.
• Average Amortization of Deferred Charges over 5 years is $1.7 million, with a median of $436000.0 recorded in 2013.
• Across the five-year window, Amortization of Deferred Charges surged 165.36% in 2015 and slumped 91.46% in 2016, its largest moves.
• Year by year, Amortization of Deferred Charges stood at $4.5 million in 2012, then tumbled by 90.26% to $437000.0 in 2013, then dropped by 2.29% to $427000.0 in 2014, then declined by 3.98% to $410000.0 in 2015, then advanced by 23.41% to $506000.0 in 2016.
• According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $506000.0, $34000.0, and $1.9 million for Q4 2016, Q3 2016, and Q2 2016 respectively.